About Us

Johnson & Johnson to Participate in the Leerink Global Biopharma Conference

Johnson & Johnson (NYSE: JNJ) will participate in the Leerink Global Biopharma Conference on Tuesday, March 12th, at the Fontainebleau Miami Beach, FL. Joe Wolk, Executive Vice President, Chief Financial Officer will represent the Company in a session scheduled at 1:00 p.m. (Eastern Time).

This live audio webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

The audio webcast replay will be available approximately 48-hrs after the webcast.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  249.15
-0.17 (-0.07%)
AAPL  270.40
+0.36 (0.13%)
AMD  257.50
+7.45 (2.98%)
BAC  52.75
-0.79 (-1.48%)
GOOG  284.50
+6.44 (2.32%)
META  638.28
+10.96 (1.75%)
MSFT  508.33
-6.00 (-1.17%)
NVDA  200.94
+2.25 (1.13%)
ORCL  251.54
+3.37 (1.36%)
TSLA  462.13
+17.88 (4.02%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.